MWT Test: How It Measures Alertness and Driving Safety

The Maintenance of Wakefulness Test, commonly called the MWT, is a clinical sleep study that measures your ability to stay awake in a quiet, dimly lit room. Unlike its better-known cousin the Multiple Sleep Latency Test (MSLT), which measures how quickly you fall asleep when given the chance, the MWT measures how effectively you can resist sleep when you are trying to stay awake. That distinction matters more than it sounds, because the two tests capture different aspects of daytime functioning and do not always agree on how impaired a person is.

What the MWT Actually Measures

The core idea is straightforward: you sit in a comfortable chair in a dim room and try not to fall asleep. The test records how long you manage to stay awake before drifting off. That time, measured in minutes, is your sleep onset latency (SOL). The longer you last, the better your ability to maintain wakefulness. A full test session typically involves four or five separate trials spread across the day, each lasting up to 40 minutes, with the results averaged to produce a single score.

What makes this clinically useful is that it taps into something fundamentally different from what the MSLT captures. The MSLT asks you to lie down in a dark room and try to fall asleep, essentially measuring how strong your sleep drive is. The MWT puts you upright and asks you to fight that drive off. Research has shown that the correlation between the two tests is modest at best. One early study found a correlation of only 0.41 between MWT and MSLT scores, meaning less than 17 percent of the variability between the two tests was shared.¹ Some patients who fell asleep rapidly on the MSLT were perfectly capable of staying awake when asked to do so on the MWT, and others who struggled to stay awake on the MWT did not fall asleep quickly on the MSLT.

The reason for this disconnect is that the MWT engages both the sleep system and the arousal system. When you sit upright and actively try to remain alert, motivation and posture both contribute to keeping you awake. The MSLT, in ideal conditions, strips those arousal factors away and isolates sleepiness alone. Research has confirmed that these arousal effects in the MWT are additive, meaning both the instruction to stay awake and the upright posture independently push sleep latency higher.² That is precisely why the MWT is the preferred test when the clinical question is not “how sleepy is this person?” but rather “can this person stay awake when they need to?”

How the Test Is Performed

The American Academy of Sleep Medicine (AASM) has published detailed protocols covering how the MWT should be set up, including guidance on patient preparation, medication and substance use, prior sleep, scheduling, room conditions, and documentation.³ In practice, the test usually happens the day after an overnight sleep study (polysomnography) to confirm you slept a reasonable amount the night before.

During each trial, you sit semi-reclined in bed with low lighting. Electrodes are placed on your scalp, face, and chin to record brain waves (EEG), eye movements (EOG), and muscle tone (EMG). The EEG montage typically includes frontal, central, and occipital channels, giving technicians a clear picture of whether you are awake or transitioning into sleep.⁴ A trained scorer reviews 30-second segments of the recording after each trial. Sleep onset is defined either as the first single epoch of any sleep stage or, more conservatively, as three consecutive epochs of light sleep or one epoch of deeper sleep. The definition used can affect the resulting score, so it is important to know which criterion a lab applies.

Trials are spaced about two hours apart across the day, typically starting around mid-morning. Between trials, you are asked to stay awake, avoid vigorous exercise, and not consume caffeine or other stimulants. If you stay awake for the entire 40-minute trial, you score 40 for that trial. The mean across all trials becomes your MWT score.

What Counts as a Normal Score

Establishing what “normal” means on the MWT has been tricky, because healthy people almost never fall asleep during the test. In a study of healthy subjects given 40-minute trials, the mean sleep latency was about 35 to 37 minutes, with most people staying awake the full 40 minutes.⁵ The lower normal limit in that study, defined as two standard deviations below the mean, came out to roughly 26 minutes. An earlier normative study using a slightly different scoring approach placed the mean at about 35 minutes and the lower limit at roughly 19 minutes.⁶

A more recent study looking at well-treated, non-sleepy patients with obstructive sleep apnea found a mean sleep latency of about 38 minutes, with 80 percent of them staying awake through every trial. The lower normal limit in that group was 30 minutes.⁷ These varying thresholds are a genuine source of clinical debate. Depending on which cutoff a clinician uses, a patient scoring 25 minutes could be classified as impaired or normal. In practice, many clinicians treat scores below about 19 to 20 minutes as clearly abnormal, scores above 33 to 34 minutes as clearly normal, and scores in between as a gray zone that requires clinical judgment.

Obstructive Sleep Apnea and Treatment Monitoring

One of the most common reasons people undergo an MWT is to evaluate residual daytime sleepiness in obstructive sleep apnea (OSA), particularly after treatment with continuous positive airway pressure (CPAP) has begun. The test can help answer whether treatment is restoring a person’s ability to stay alert during the day.

In a study of 24 OSA patients, mean MWT sleep latency increased from about 18 minutes before CPAP to about 32 minutes after treatment.⁸ Baseline MWT scores also turned out to be a useful predictor of how much improvement a patient would see. Those with worse starting latencies tended to show larger gains after treatment, though the degree of improvement also depended on how consistently the patient used CPAP and how disrupted their sleep architecture was to begin with.⁹

One thing clinicians have noticed is that subjective sleepiness questionnaires and MWT results do not always tell the same story. In treated OSA patients, one study found only a moderate correlation between the Epworth Sleepiness Scale (ESS) and MWT scores, and no correlation at all between the change in ESS and the change in MWT over time.¹⁰ A patient might report feeling much more alert on a questionnaire while still showing a short sleep latency on the MWT, or vice versa. That gap is why many regulatory and occupational guidelines rely on the MWT rather than self-report when the stakes are high.

Narcolepsy and Hypersomnia

The MWT plays a different but equally important role in narcolepsy and other disorders of excessive daytime sleepiness. In narcolepsy, the problem is not obstruction of breathing but a fundamental breakdown in the brain’s ability to regulate sleep-wake transitions. The MWT helps quantify how severe that breakdown is and, more practically, whether medication is improving things.

A large study of 530 narcolepsy patients found a mean MWT sleep latency of just 6 minutes, compared with the 35-plus minutes seen in healthy controls. Only about 1.5 percent of narcolepsy patients managed to stay awake through all four 20-minute trials, versus roughly 55 percent of controls in a separate sample.¹¹ That dramatic gap makes the MWT a useful yardstick for measuring the effect of wake-promoting drugs.

In children with narcolepsy, the MWT has also shown promise for tracking treatment response, though with a much thinner evidence base. A small pediatric series reported that MWT results led to changes in management in the majority of the patients tested, suggesting the test can be clinically useful even in younger populations.¹² However, the AASM has stated that there is currently not enough evidence to specify a recommended MWT protocol for children and adolescents, so pediatric use remains somewhat ad hoc.¹³

Driving Risk and Real-World Safety

Here is where the MWT becomes more than an academic measurement. Regulatory bodies in several countries use MWT results to help decide whether a patient with a sleep disorder is safe to drive, particularly for commercial vehicle operators. The logic is intuitive: if you cannot stay awake in a quiet, comfortable room, you are unlikely to reliably stay awake behind the wheel.

The evidence connecting MWT scores to driving performance is not perfect, but it is consistent enough to be taken seriously. In a study of OSA patients performing a standardized driving simulation, MWT scores correlated with the number of inappropriate line crossings on the simulated road. Patients classified as “very sleepy” (MWT scores below 19 minutes) and “sleepy” (20 to 33 minutes) had significantly more lane deviations than alert patients and healthy controls.¹⁴ In patients with narcolepsy and hypersomnia, similar correlations between MWT scores and simulated driving performance have been reported, though with moderate effect sizes.¹⁵

Perhaps the most compelling data come from a study linking MWT scores to self-reported near-miss incidents and actual accidents. Patients with MWT latencies between 19 and 33 minutes had roughly a threefold increase in near-miss or accident risk compared with those scoring above 33 minutes, and patients with latencies below 19 minutes had about a fivefold increase.¹⁶ Those numbers help explain why many licensing authorities have adopted MWT thresholds as part of fitness-to-drive evaluations, though the specific cutoff used varies by country and jurisdiction.

Why Subjective and Objective Sleepiness Do Not Match

One of the most frustrating aspects of sleepiness for both patients and clinicians is that how sleepy you feel and how sleepy you measurably are can be two different things. The ESS, a simple eight-question survey about how likely you are to doze off in various situations, is the most widely used subjective measure. It correlates with MWT scores, but the correlation is weak enough to be clinically unreliable at the individual level.

In two large clinical trials of sodium oxybate for narcolepsy, the correlation between ESS and MWT ranged from about −0.27 to −0.43 across different time points.¹⁷ The negative sign simply reflects opposite scoring directions: higher ESS means sleepier, while higher MWT means more alert. But the magnitude tells the story. A correlation in that range means the two measures share only about 7 to 18 percent of their variability. In practical terms, knowing someone’s ESS score gives you only a rough guess at their MWT score.

An earlier study found something even more interesting: at the severe end of the sleepiness spectrum, the ESS essentially flattened out. People with very low MWT scores (severely impaired ability to stay awake) did not rate themselves as proportionally sleepier on the ESS. The subjective scale lost sensitivity precisely where it mattered most.¹⁸ One analysis of receiver-operating characteristic curves even found the MSLT to be the least discriminating of the three common sleepiness tests, with the ESS performing best and the MWT falling in between.¹⁹ These findings challenge the long-standing assumption that the MSLT is the gold standard for measuring daytime sleepiness.

How Medications Affect MWT Scores

The MWT has become a standard endpoint in clinical trials of wake-promoting drugs, particularly for narcolepsy and residual sleepiness in treated OSA. The test’s sensitivity to pharmacological intervention makes it a practical tool for showing regulators that a medication actually helps patients stay awake.

Modafinil, one of the most widely prescribed medications for excessive daytime sleepiness, has been shown across pooled trial data to improve MWT scores by about 3.5 minutes on average in narcolepsy patients.²⁰ That may sound small, but remember that the MWT has a ceiling of 40 minutes and many narcolepsy patients start with latencies under 10 minutes, so a gain of several minutes represents a meaningful shift.

Newer medications show larger effects. A network meta-analysis comparing wake-promoting agents found that solriamfetol at its highest studied dose extended MWT sleep latency by roughly 11 minutes compared with placebo in narcolepsy.²¹ In OSA patients with residual sleepiness despite CPAP use, solriamfetol again showed the largest MWT improvement, followed by modafinil and armodafinil.²²

A newer class of drugs, selective orexin receptor agonists, is also being evaluated using the MWT. Early-phase trial data for danavorexton in narcolepsy type 1 and type 2 showed significant increases in MWT sleep latency and, interestingly, significant reductions in microsleeps during the test.²³ These microsleep measures point toward a richer way of interpreting MWT data than the single sleep-latency number.

Beyond Sleep Latency and New Biomarkers

The traditional MWT endpoint is a single number: how many minutes until you fell asleep. That is useful, but it throws away a lot of information contained in the EEG recording. Researchers are beginning to extract additional measures from MWT recordings that may capture different dimensions of sleepiness.

Microsleeps, brief intrusions of sleep lasting just a few seconds, are one example. They can occur even during trials where the patient technically “stays awake” long enough to score well on the standard latency measure. In narcolepsy research, the rate and duration of microsleeps during MWT trials correlated highly with the standard sleep latency score and responded to drug treatment in a dose-dependent way.²⁴ A related approach uses automated sleep scoring to generate a minute-by-minute probability of wakefulness throughout the trial, producing a “sleepiness slope” that captures how quickly a person drifts toward sleep after lights go out. The steepness of that slope correlated with standard MWT latency at very high levels in both narcolepsy type 1 and type 2.

These EEG-derived biomarkers are still in the research phase, but they hint at a future where the MWT provides a more nuanced readout. A patient who scores 30 minutes on sleep latency but shows frequent microsleeps and a steep sleepiness slope throughout the trial might be at higher functional risk than another patient with the same latency but a flat, stable wake pattern. For now, the standard sleep-latency score remains the clinical currency, but that could change as automated scoring tools mature.

How the MWT Compares to Other Sleepiness Measures

A reasonable question is whether the MWT is even the best tool for the job, given its cost, complexity, and the fact that it requires a full day in a sleep lab. The psychomotor vigilance test (PVT), a simple reaction-time task that can be administered in minutes, is often used in research settings and has its own advocates. A comparative analysis found that the MWT and MSLT were more sensitive than the PVT to total sleep deprivation, but all three measures performed comparably in detecting the effects of chronic sleep restriction.²⁵ The PVT and MWT also showed comparable sensitivity to interventions like wake-promoting drugs, suggesting they may be somewhat interchangeable in that context.

The MWT’s unique advantage is that it directly measures the ability to resist sleep under standardized conditions, which maps more cleanly onto safety-critical scenarios like driving or operating machinery than a reaction-time test does. A PVT can tell you that someone’s attention is degraded, but only the MWT can tell you whether they actually fell asleep when sitting still and trying not to. That direct behavioral measurement is what makes it the preferred tool for occupational and regulatory decisions, even though it is expensive and time-consuming.

Practical Considerations for Patients

If you have been told you need an MWT, a few things are worth knowing ahead of time. The test takes most of a day, typically four trials spaced two hours apart. You will likely be asked to avoid caffeine, nicotine, and certain medications in the days leading up to the test, because all of these can artificially inflate your scores. You will also usually undergo an overnight sleep study the night before, partly to document your sleep quality and partly to ensure you got enough sleep to make the MWT results interpretable.

Between trials, you will be awake in the lab with limited activity options. Bring something quiet to occupy yourself, but expect restrictions on things like vigorous exercise, bright light exposure, and napping. The goal is to keep your arousal level roughly neutral so the test conditions are consistent across trials.

One common source of anxiety is the fear of “passing” or “failing.” If the test is being done for a fitness-to-drive evaluation, the stakes feel high, and patients sometimes try to game the result by moving around, talking to themselves, or using other strategies to stay awake. Sleep lab technicians are trained to watch for this, and the EEG recording can reveal patterns of compensatory effort. The test works best when you simply sit quietly and let it measure your natural ability to maintain wakefulness. Trying to cheat it generally produces data that is harder to interpret, not data that looks better.

If your MWT score falls in the gray zone, somewhere between the lower normal limit and a clearly abnormal value, expect a conversation rather than a verdict. Your clinician will weigh the MWT result alongside your clinical history, treatment adherence, subjective symptoms, and the specific reason the test was ordered. A borderline score in someone who has been consistently using CPAP and reports feeling alert is interpreted very differently from the same score in someone who just started treatment and is still struggling.